Trial Profile
Post Marketing Surveillance Study of Safety and Efficacy of Samsca® Tablets Under the "New Drug Re-Examination"
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Adverse reactions
- Acronyms Samsca PMS
- Sponsors Korea Otsuka Pharmaceutical
- 13 Aug 2018 Status changed from recruiting to completed.
- 02 Apr 2016 New trial record